Reynolds developed a panel of five proteins (S100B, B–type neurotrophic growth factor, von Willebrand factor, matrix metalloproteinase–9, and monocyte chemotactic protein–1) that appears to be capable of diagnosing a stroke with sensitivity and specificity above 90% [4]. The gene discussed is S100B; the disease is stroke disorder.